Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients (Q39735514)

14 September 2017

Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients (English)

1 reference

14 September 2017

0 references

4

Vincent Soriano

1 reference

14 September 2017

Oscar Gallego

1

1 reference

14 September 2017

Carmen de Mendoza

series ordinal

2

1 reference

14 September 2017

Angélica Corral

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of Clinical Microbiology

14 September 2017

1 reference

14 September 2017

41

1 reference

14 September 2017

3

1 reference

14 September 2017

1245-1247

1 reference

Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

International perspectives on antiretroviral resistance. Resistance to protease inhibitors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

HIV treatment failure: testing for HIV resistance in clinical practice

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150303

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12624058

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Emergence of zidovudine resistance in HIV-infected patients receiving stavudine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12624058

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12624058

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/JCM.41.3.1245-1247.2003

1 reference

14 September 2017

1 reference

14 September 2017

1 reference